Seale & Associates acted as exclusive financial advisor to Invekra, assisting with comprehensive research on the Peruvian pharmaceutical market and the prioritization of potential acquisition targets.
Seale completed a thorough screening of the potential universe of pharmaceutical companies that would align with Invekra’s strategy.
Seale pre-qualified each potential target and initiated transaction discussions with the targets that best fit Invekra’s strategy and investment criteria.
The process resulted in a successful acquisition of Laboratorios Portugal S.R.L by Invekra, a conglomerate of 12 Latin American pharmaceutical companies. The acquisition strengthens Invekra’s presence in Latin America.